High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients

High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients

BackgroundMultiple myeloma (MM) is a malignant proliferative disease of the blood system, characterized by the abnormal growth of clonal plasma cells in the bone marrow. The bone marrow microenvironment (BMM) is highly critical in the pathological process of MM. Many studies have shown that serum in...

Full description

Bibliographic Details
Main Authors: Mengmeng Dong, Jinna Zhang, Qingxiao Chen, Donghua He, Haimeng Yan, Gaofeng Zheng, Xiaoyan Han, Jingsong He, Zhen Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
IL-17A
multiple myeloma
bone destruction
best overall therapeutic effect
pfs
os
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.936670/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.936670/full

Similar Items